MRF.NS(MRF.NS)
MRF.NS
No analyst ratings available
No analyst price targets available for MRF.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $346.09B | $376.17B | $399.97B |
| Low | $338.73B | $360.08B | $386.74B |
| High | $359.26B | $392.92B | $406.93B |
| EBITDA Avg | $53.07B | $63.81B | $72.86B |
| Low | $49.26B | $60.66B | $69.63B |
| High | $55.16B | $70.68B | $76.60B |
| EBIT Avg | $33.37B | $41.88B | $48.76B |
| Low | $29.55B | $38.73B | $45.54B |
| High | $35.46B | $48.75B | $52.50B |
| Net Income Avg | $22.07B | $28.39B | $33.49B |
| Low | $19.24B | $26.05B | $31.10B |
| High | $23.62B | $33.49B | $36.27B |
| EPS Avg | $5010.84 | $6673.54 | $7852.86 |
| Low | $4537.33 | $6143.25 | $7333.17 |
| High | $5570.54 | $7895.75 | $8551.95 |
| Analysts (Rev / EPS) | 8 / 6 | 8 / 8 | 4 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $82.22B | $88.36B | $87.03B |
| Low | $82.22B | $88.36B | $87.03B |
| High | $82.22B | $88.36B | $87.03B |
| EBITDA Avg | $10.89B | $12.53B | $13.15B |
| Low | $10.89B | $12.53B | $13.15B |
| High | $10.89B | $12.53B | $13.15B |
| EBIT Avg | $6.30B | $7.81B | $8.30B |
| Low | $6.30B | $7.81B | $8.30B |
| High | $6.30B | $7.81B | $8.30B |
| Net Income Avg | $4.01B | $5.13B | $5.50B |
| Low | $4.01B | $5.13B | $5.50B |
| High | $4.01B | $5.13B | $5.50B |
| EPS Avg | $946.40 | $1210.40 | $1297.40 |
| Low | $946.40 | $1210.40 | $1297.40 |
| High | $946.40 | $1210.40 | $1297.40 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |